Current development and challenges of tetravalent live-attenuated dengue vaccines
Dengue is the most common arboviral disease caused by one of four distinct but closely
related dengue viruses (DENV) and places significant economic and public health burdens …
related dengue viruses (DENV) and places significant economic and public health burdens …
A perspective on current flavivirus vaccine development: a brief review
SK Dutta, T Langenburg - Viruses, 2023 - mdpi.com
The flavivirus genus contains several clinically important pathogens that account for
tremendous global suffering. Primarily transmitted by mosquitos or ticks, these viruses can …
tremendous global suffering. Primarily transmitted by mosquitos or ticks, these viruses can …
A modified mRNA vaccine targeting immunodominant NS epitopes protects against dengue virus infection in HLA class I transgenic mice
C Roth, T Cantaert, C Colas, M Prot… - Frontiers in …, 2019 - frontiersin.org
Dengue virus (DENV) induces strong T and B cell responses upon infection. Hence, it is
difficult to determine the contribution of cell-mediated immunity alone in the long lasting …
difficult to determine the contribution of cell-mediated immunity alone in the long lasting …
Challenges in dengue vaccines development: pre-existing infections and cross-reactivity
AM Izmirly, SO Alturki, SO Alturki, J Connors… - Frontiers in …, 2020 - frontiersin.org
Dengue is one of the most frequently transmitted mosquito-borne diseases in the world,
which creates a significant public health concern globally, especially in tropical and …
which creates a significant public health concern globally, especially in tropical and …
Recent developments in recombinant protein–based dengue vaccines
NK Tripathi, A Shrivastava - Frontiers in immunology, 2018 - frontiersin.org
Recombinant proteins are gaining enormous importance these days due to their wide
application as biopharmaceutical products and proven safety record. Various recombinant …
application as biopharmaceutical products and proven safety record. Various recombinant …
Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics
X Zhang, Y Zhang, R Jia, M Wang, Z Yin, A Cheng - Veterinary research, 2021 - Springer
Flaviviruses are enveloped single positive-stranded RNA viruses. The capsid (C), a
structural protein of flavivirus, is dimeric and alpha-helical, with several special structural …
structural protein of flavivirus, is dimeric and alpha-helical, with several special structural …
The nucleocapsid protein of SARS-CoV-2, combined with ODN-39M, is a potential component for an intranasal bivalent vaccine with broader functionality
Y Lobaina, R Chen, E Suzarte, P Ai, V Huerta… - Viruses, 2024 - mdpi.com
Despite the rapid development of vaccines against COVID-19, they have important
limitations, such as safety issues, the scope of their efficacy, and the induction of mucosal …
limitations, such as safety issues, the scope of their efficacy, and the induction of mucosal …
Flavivirus vaccines: virus-like particles and single-round infectious particles as promising alternatives
The genus flavivirus of the Flaviridae family includes several human pathogens, like
dengue, Zika, Japanese encephalitis, and yellow fever virus. These viruses continue to be a …
dengue, Zika, Japanese encephalitis, and yellow fever virus. These viruses continue to be a …
[HTML][HTML] Dengue vaccine–induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies
JH Lam, YL Chua, PX Lee, JMM Gómez, EE Ooi… - JCI insight, 2017 - ncbi.nlm.nih.gov
Declining levels of maternal antibodies were shown to sensitize infants born to dengue-
immune mothers to severe disease during primary infection, through the process of antibody …
immune mothers to severe disease during primary infection, through the process of antibody …
Can complementary prime-boost immunization strategies be an alternative and promising vaccine approach against dengue virus?
Dengue is one of the most important diseases transmitted by mosquitoes. Dengvaxia®, a
vaccine registered in several countries, cannot be administered to non-immune individuals …
vaccine registered in several countries, cannot be administered to non-immune individuals …